These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23918355)

  • 1. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells.
    Kim KT; Jeong HC; Kim CY; Kim EY; Heo SH; Cho SJ; Hong KS; Cha HJ
    J Dermatol Sci; 2017 May; 86(2):123-131. PubMed ID: 28185769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
    Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
    Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
    Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
    Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical approaches to induce selective cell death of pluripotent stem cells.
    Jeong HC; Cho SJ; Lee MO; Cha HJ
    Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.
    Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM
    Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumorigenicity of diploid and aneuploid human pluripotent stem cells.
    Blum B; Benvenisty N
    Cell Cycle; 2009 Dec; 8(23):3822-30. PubMed ID: 19887907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
    Kim A; Lee SY; Seo CS; Chung SK
    Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells.
    Go YH; Kim J; Jeong HC; Kim SM; Kim YJ; Park SJ; Moon SH; Cha HJ
    Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33121085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
    Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
    Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas.
    Lee AS; Tang C; Hong WX; Park S; Bazalova-Carter M; Nelson G; Sanchez-Freire V; Bakerman I; Zhang W; Neofytou E; Connolly AJ; Chan CK; Graves EE; Weissman IL; Nguyen PK; Wu JC
    Stem Cells; 2017 Aug; 35(8):1994-2000. PubMed ID: 28600830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser-assisted photoablation of human pluripotent stem cells from differentiating cultures.
    Terstegge S; Winter F; Rath BH; Laufenberg I; Schwarz C; Leinhaas A; Levold F; Dolf A; Haupt S; Koch P; Endl E; Brüstle O
    Stem Cell Rev Rep; 2010 Jun; 6(2):260-9. PubMed ID: 20186504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
    Kim A; Lee SY; Seo CS; Chung SK
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
    Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
    Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells.
    Setoguchi K; TeSlaa T; Koehler CM; Teitell MA
    J Mol Biol; 2016 Apr; 428(7):1465-75. PubMed ID: 26239243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2.
    Tan HL; Tan BZ; Goh WXT; Cua S; Choo A
    Biotechnol Bioeng; 2019 Nov; 116(11):2996-3005. PubMed ID: 31388993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.
    Salvatori DCF; Dorssers LCJ; Gillis AJM; Perretta G; van Agthoven T; Gomes Fernandes M; Stoop H; Prins JB; Oosterhuis JW; Mummery C; Looijenga LHJ
    Stem Cell Reports; 2018 Dec; 11(6):1493-1505. PubMed ID: 30503260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.
    Adler-Wailes DC; Kramer JA; DePamphilis ML
    Stem Cells Dev; 2017 Feb; 26(4):285-302. PubMed ID: 27821018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.